loading
前日終値:
$2.69
開ける:
$2.68
24時間の取引高:
20,763
Relative Volume:
0.24
時価総額:
$35.32M
収益:
-
当期純損益:
$-70.20M
株価収益率:
-0.0614
EPS:
-44.82
ネットキャッシュフロー:
$-50.66M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+27.31%
6か月 パフォーマンス:
-46.39%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$2.6109
$2.75
1週間の範囲:
Value
$2.55
$2.975
52週間の値動き範囲:
Value
$1.70
$19.40

Onkure Therapeutics Inc Stock (OKUR) Company Profile

Name
名前
Onkure Therapeutics Inc
Name
セクター
Healthcare (1149)
Name
電話
(720) 307-2892
Name
住所
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
Name
職員
46
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
OKUR's Discussions on Twitter

OKUR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
OKUR
Onkure Therapeutics Inc
2.75 36.40M 0 -70.20M -50.66M -44.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.12 101.77B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.38 60.12B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.00 59.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
750.78 44.90B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.80 35.07B 3.81B -644.79M -669.77M -6.24

Onkure Therapeutics Inc Stock (OKUR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-30 開始されました Evercore ISI Outperform
2024-12-05 開始されました Leerink Partners Outperform
2024-10-10 開始されました Oppenheimer Outperform
2023-12-15 ダウングレード H.C. Wainwright Buy → Neutral
2023-12-15 ダウングレード Jefferies Buy → Hold
2023-12-15 ダウングレード Leerink Partners Outperform → Market Perform
2023-12-14 ダウングレード BofA Securities Buy → Underperform
2023-12-14 ダウングレード Ladenburg Thalmann Buy → Neutral
2023-12-14 ダウングレード Piper Sandler Overweight → Neutral
2023-12-14 ダウングレード Robert W. Baird Outperform → Neutral
2023-12-14 ダウングレード William Blair Outperform → Mkt Perform
2023-11-15 開始されました William Blair Outperform
2023-08-28 開始されました H.C. Wainwright Buy
2023-07-03 開始されました BofA Securities Buy
2022-09-19 再開されました H.C. Wainwright Buy
2022-01-27 開始されました Robert W. Baird Outperform
2021-12-21 開始されました H.C. Wainwright Buy
2021-11-22 開始されました Ladenburg Thalmann Buy
2021-05-04 開始されました Jefferies Buy
2021-05-04 開始されました Piper Sandler Overweight
2021-05-04 開始されました SVB Leerink Outperform
すべてを表示

Onkure Therapeutics Inc (OKUR) 最新ニュース

pulisher
07:53 AM

What to expect from OnKure Therapeutics Inc. in the next 30 days2025 Trading Volume Trends & Accurate Entry/Exit Alerts - Newser

07:53 AM
pulisher
Sep 06, 2025

Key metrics from OnKure Therapeutics Inc.’s quarterly dataWeekly Trade Summary & Technical Pattern Based Signals - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Strategies to average down on OnKure Therapeutics Inc.Market Performance Summary & Risk Controlled Swing Alerts - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Using economic indicators to assess OnKure Therapeutics Inc. potentialSwing Trade & Risk Managed Investment Strategies - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Real time alert setup for OnKure Therapeutics Inc. performance2025 Dividend Review & Community Supported Trade Ideas - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

How to build a custom watchlist for OnKure Therapeutics Inc.Weekly Trend Summary & AI Driven Price Predictions - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Is OnKure Therapeutics Inc. still worth holding after the dipTreasury Yields & Advanced Swing Trade Entry Alerts - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

What to do if you’re stuck in OnKure Therapeutics Inc.Quarterly Profit Review & Technical Pattern Recognition Alerts - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Has OnKure Therapeutics Inc. formed a bullish divergence2025 Key Highlights & Community Verified Swing Trade Signals - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Is a relief rally coming for OnKure Therapeutics Inc. holdersMarket Risk Report & Free Reliable Trade Execution Plans - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

How to build a dashboard for OnKure Therapeutics Inc. stock2025 Valuation Update & Long-Term Growth Stock Strategies - Newser

Sep 06, 2025
pulisher
Sep 05, 2025

Can OnKure Therapeutics Inc. expand into new marketsWeekly Investment Recap & Reliable Volume Spike Trade Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

How to track smart money flows in OnKure Therapeutics Inc.July 2025 Snapshot & AI Enhanced Market Trend Forecasts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

How sensitive is OnKure Therapeutics Inc. to inflation2025 Buyback Activity & Risk Controlled Daily Plans - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Using RSI to spot recovery in OnKure Therapeutics Inc.Weekly Stock Analysis & Daily Growth Stock Investment Tips - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Can OnKure Therapeutics Inc. hit a new high this monthJuly 2025 Short Interest & Consistent Income Trade Recommendations - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is OnKure Therapeutics Inc. stock bottoming outTrade Volume Report & Reliable Intraday Trade Alerts - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Building trade automation scripts for OnKure Therapeutics Inc.Volume Spike & Free Daily Entry Point Trade Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Screener Results Flag OnKure Therapeutics Inc. as Oversold2025 Year in Review & Weekly Stock Performance Updates - beatles.ru

Sep 04, 2025
pulisher
Sep 04, 2025

Market reaction to OnKure Therapeutics Inc.’s recent newsTrade Analysis Report & Consistent Profit Focused Trading Strategies - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Published on: 2025-09-04 06:05:03 - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

What does recent volatility data suggest for OnKure Therapeutics Inc.Earnings Recap Summary & Fast Entry High Yield Tips - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

What moving averages say about OnKure Therapeutics Inc.Quarterly Earnings Report & Real-Time Volume Analysis - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How sentiment analysis helps forecast OnKure Therapeutics Inc.2025 Trade Ideas & Scalable Portfolio Growth Ideas - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Developing predictive dashboards with OnKure Therapeutics Inc. dataEarnings Summary Report & AI Driven Price Predictions - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Is OnKure Therapeutics Inc. impacted by rising ratesEarnings Risk Report & Low Risk High Win Rate Stock Picks - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

What’s the MACD signal for OnKure Therapeutics Inc.2025 Risk Factors & Real-Time Chart Breakout Alerts - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

When is the best time to exit OnKure Therapeutics Inc.Trade Entry Report & Reliable Price Action Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 07:13:09 - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

OnKure Therapeutics Inc. stock daily chart insightsJuly 2025 Update & High Yield Stock Recommendations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

OnKure Therapeutics Inc. recovery potential after sell offPortfolio Risk Report & Safe Entry Zone Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Leading vs lagging indicators on OnKure Therapeutics Inc. performanceEarnings Overview Summary & Advanced Technical Signal Analysis - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using data models to predict OnKure Therapeutics Inc. stock movementWeekly Risk Summary & Precise Trade Entry Recommendations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is OnKure Therapeutics Inc. a strong growth stockQuarterly Profit Report & Technical Buy Zone Confirmations - خودرو بانک

Sep 03, 2025

Onkure Therapeutics Inc (OKUR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Onkure Therapeutics Inc (OKUR) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Leverone Jason A.
Chief Financial Officer
Jun 23 '25
Sale
2.38
303
722
12,906
Cormorant Asset Management, LP
Former 10% Owner
May 15 '25
Sale
1.85
1,813,439
3,363,023
0
ACORN BIOVENTURES, L.P.
10% Owner
May 15 '25
Buy
1.85
1,129,730
2,090,000
1,129,730
ACORN BIOVENTURES, L.P.
10% Owner
May 15 '25
Buy
1.85
270,270
500,000
1,709,944
Cormorant Asset Management, LP
10% Owner
May 12 '25
Sale
1.99
24,300
48,236
1,813,439
Saccomano Nicholas A
President and CEO
Apr 07 '25
Sale
2.67
516
1,378
3,682
Saccomano Nicholas A
President and CEO
Apr 04 '25
Sale
3.33
358
1,191
4,198
Leverone Jason A.
Chief Financial Officer
Apr 07 '25
Sale
2.67
1,844
4,925
13,209
Leverone Jason A.
Chief Financial Officer
Apr 04 '25
Sale
3.33
1,278
4,253
15,053
Leonard Braden Michael
10% Owner
Sep 25 '24
Buy
1.50
68,746
102,872
3,457,395
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
大文字化:     |  ボリューム (24 時間):